MAIABiotech.com (MAIA) - Volume dana dhuwit perusahaan

Simbol resmi perusahaan MAIA Biotechnology (MAIA)

The cash position chart demonstrates the liquidity of MAIA Biotechnology, where 0.02 determines this parameter level. MAIA Biotechnology is developing an innovative platform to combat severe oncological pathologies by targeting telomeres. The current pre-revenue stage implies a constant capital outflow for research prior to the commercialization of drugs. Meanwhile, a narrow specialization in a single therapy method creates a high dependency on the outcome of clinical tests.

MAIA - Cadangan dhuwit perusahaan MAIA Biotechnology Inc ing rentang 28.04.2023 - 21.11.2026

Rincian analitis perusahaan MAIA Biotechnology

Pambiji fundamental perusahaan:MAIA Biotech MAIA
Produk merek MAIA Biotechnology, Inc.

Investors are assessing the resilience of MAIA Biotechnology (MAIA) through the volume of highly liquid assets, which determine the company's ability to fund costly anti-tumor drug development without the urgent need for debt financing. This metric captures the actual cash balance as of the reporting date, reflecting the real margin of safety for conducting clinical trials. By analyzing changes in the cash balance, one can determine the business's autonomy horizon until the therapy reaches commercialization.

Pesaing MAIA Biotechnology (MAIA)

Dhuwit awis perusahaan IBRX (ImmunityBio Corp)|Gunggung dana dhuwit perusahaan IMCR|Volume dana dhuwit perusahaan JANX (Janux Therapeutics, Inc.)|Sisa dhuwit perusahaan RCUS|zymeworks.com - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Tango Therapeutics Corp|Iovance Biotherapeutics (IOVA) - Dana dhuwit perusahaan|Immatics N.V. - Sisa dhuwit perusahaan|XNCR (xencor.com) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan Compass Therapeutics Inc|Dana dhuwit perusahaan Replimune (REPL)|LYEL: Total volume dana dhuwit perusahaan|Innate Pharma SA - Dhuwit awis perusahaan|Pyxis Oncology, Inc. (PYXS) - Cadangan dhuwit perusahaan|Compugen - Volume dana dhuwit perusahaan|Aset likuid perusahaan IO Biotech Inc IOBT|STRO (Sutro Biopharma Inc.) - Dhuwit awis perusahaan|INKT - Aset likuid perusahaan|Dana dhuwit perusahaan werewolftx.com|Dhuwit awis perusahaan Immix Biopharma, Inc. (IMMX)|Dhuwit awis perusahaan ALXO (ALX Oncology Holdings)|Dana dhuwit perusahaan CUE (Cue Biopharma)|Volume dana dhuwit perusahaan PDSB (PDS Biotechnology Corp)|sonnetbio.com (SONN) - Cadangan dhuwit perusahaan|Liminatus - Volume dana dhuwit perusahaan|lavatherapeutics.com - Gunggung dana dhuwit perusahaan|NextCure (NXTC) - Dana dhuwit perusahaan|Leap Therapeutics Inc - Sisa dhuwit perusahaan|Dhuwit awis perusahaan INTS|Dana dhuwit perusahaan SNSE|Volume dana dhuwit perusahaan TOVX|GRTS - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan kinetabio.com KA|Sisa dhuwit perusahaan NEXI|turnstonebio.com - Volume dana dhuwit perusahaan|VCNX (Vaccinex, Inc) - Dhuwit awis lan setara dhuwit awis perusahaan|Harpoon Therapeutics (HARP) - Dana dhuwit perusahaan